借力推动前列腺癌 CAR-T 细胞治疗进展
Piggybacking toward Progress for CAR T-Cell Therapy in Prostate Cancer.
肿瘤细胞治疗研究
英文原题:A fatty acid metabolism-based deep learning model predicts biochemical recurrence and identifies NUDT19 as a candidate metabolic factor in prostate cancer.
A fatty acid metabolism-based deep learning model predicts biochemical recurrence and identifies NUDT19 as a candidate metabolic factor in prostate cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
本研究建立了一种基于脂肪酸代谢的深度学习模型用于 BCR 预测,并将 NUDT19 鉴定为与脂质代谢重塑和 PCa 进展相关的候选代谢调节因子。
建立基于脂肪酸代谢的深度学习模型,用于预测前列腺癌(PCa)的生化复发(BCR),并识别与复发相关的代谢调节因子。
整合TCGA和GEO GSE70769的转录组数据,识别脂肪酸代谢相关基因并构建BCR预测深度学习模型。采用基于卷积神经网络的方法,对苏木精-伊红(H&E)染色切片中的TIL(肿瘤浸润淋巴细胞)进行定量。分析单细胞RNA测序数据,筛选富集于恶性上皮细胞中的候选代谢调节因子。通过免疫组化检测NUDT19蛋白表达模式及其与关键脂肪酸代谢酶FASN、ACACA和CPT1A的表达关联。进一步采用体外实验、异种移植模型和血清代谢组学评估其功能作用。
该模型可有效将PCa患者分为生化复发无进展生存期结局不同的高、低风险组。高风险组TIL浸润增加,提示肿瘤微环境具有更高免疫浸润或炎症水平。整合单细胞与整体转录组分析发现,NUDT19是主要表达于恶性上皮细胞中的候选代谢调节因子,且与FASN、ACACA和CPT1A呈正相关。敲低NUDT19可抑制PCa细胞增殖、迁移和侵袭,诱导凋亡,并抑制体内肿瘤生长。血清代谢组学还显示,差异代谢物富集于脂肪酸代谢相关通路。
本研究建立了基于脂肪酸代谢的BCR预测深度学习模型,并鉴定出与脂质代谢重塑及PCa进展相关的候选代谢调节因子NUDT19。结果提示存在一种代谢活跃、伴炎症特征的复发亚型,并支持进一步研究NUDT19作为潜在治疗靶点。
To develop a fatty acid metabolism-based deep learning model for predicting biochemical recurrence (BCR) in prostate cancer (PCa) and to identify recurrence-associated metabolic regulators.
Transcriptomic data from TCGA and GEO GSE70769 were integrated to identify fatty acid metabolism-related genes and construct a deep learning model for BCR prediction. Tumor-infiltrating lymphocytes (TILs) were quantified from H&E-stained slides using a convolutional neural network-based approach. Single-cell RNA sequencing data were analyzed to identify candidate metabolic regulators enriched in malignant epithelial cells. Immunohistochemistry was performed to examine the protein expression patterns of NUDT19 and its expression associations with key fatty acid metabolism enzymes, including FASN, ACACA, and CPT1A. Functional roles were further evaluated using in vitro assays, xenograft models, and serum metabolomics.
The model effectively stratified PCa patients into high- and low-risk groups with distinct BCR-free survival outcomes. The high-risk group showed increased TIL infiltration, suggesting a more immune-infiltrated or inflammatory tumor microenvironment. Integrated single-cell and bulk transcriptomic analyses identified NUDT19 as a candidate metabolic regulator predominantly expressed in malignant epithelial cells and positively correlated with FASN, ACACA, and CPT1A. NUDT19 knockdown suppressed PCa cell proliferation, migration, and invasion, induced apoptosis, and inhibited tumor growth in vivo. Serum metabolomics further revealed that differential metabolites were enriched in fatty acid metabolism-related pathways.
This study establishes a fatty acid metabolism-based deep learning model for BCR prediction and identifies NUDT19 as a candidate metabolic regulator associated with lipid metabolic remodeling and PCa progression. These findings suggest a metabolically active, inflammation-associated recurrence subtype and support further investigation of NUDT19 as a potential therapeutic target in PCa.
MEMBER ACCOUNT
登录成功会直接打开下一页。